MaxCyte, Inc. (MXCT.L)

GBp 191.4

(0.74%)

Operating Income Summary of MaxCyte, Inc.

  • MaxCyte, Inc.'s latest annual operating income in 2023 was -48.29 Million USD , down -76.53% from previous year.
  • MaxCyte, Inc.'s latest quarterly operating income in 2024 Q2 was -11.96 Million USD , up 2.5% from previous quarter.
  • MaxCyte, Inc. reported an annual operating income of -27.36 Million USD in 2022, down -50.43% from previous year.
  • MaxCyte, Inc. reported an annual operating income of -18.18 Million USD in 2021, down -64.5% from previous year.
  • MaxCyte, Inc. reported a quarterly operating income of -11.96 Million USD for 2024 Q2, up 2.5% from previous quarter.
  • MaxCyte, Inc. reported a quarterly operating income of -13.17 Million USD for 2023 Q1, down -95.21% from previous quarter.

Annual Operating Income Chart of MaxCyte, Inc. (2023 - 2012)

Historical Annual Operating Income of MaxCyte, Inc. (2023 - 2012)

Year Operating Income Operating Income Growth
2023 -48.29 Million USD -76.53%
2022 -27.36 Million USD -50.43%
2021 -18.18 Million USD -64.5%
2020 -11.05 Million USD 10.98%
2019 -12.42 Million USD -47.42%
2018 -8.42 Million USD 9.33%
2017 -9.29 Million USD -241.18%
2016 -2.72 Million USD -257.82%
2015 -761.1 Thousand USD 40.34%
2014 -1.27 Million USD -58.53%
2013 -804.7 Thousand USD 59.0%
2012 -1.96 Million USD 0.0%

Peer Operating Income Comparison of MaxCyte, Inc.

Name Operating Income Operating Income Difference